Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Arvīds Irmejs"'
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 20, Iss 1, Pp 1-7 (2022)
Abstract Background Often young women affected with BRCA1/2 positive breast cancer have not finished or even not started their childbearing before the onset of the disease. The aim of our mini-review is to summarize state of art knowledge on pregnanc
Externí odkaz:
https://doaj.org/article/26c024a2eb9a48c6a8d537c8a64c8789
Autor:
Baiba Līcīte, Arvīds Irmejs, Jeļena Maksimenko, Pēteris Loža, Genādijs Trofimovičs, Edvīns Miklaševičs, Jurijs Nazarovs, Māra Romanovska, Justīne Deičmane, Reinis Irmejs, Gunta Purkalne, Jānis Gardovskis
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-6 (2021)
Abstract Background Aim of the study is to evaluate the role of ultrasound guided fine needle aspiration cytology (FNAC) in the restaging of node positive breast cancer after preoperative systemic therapy (PST). Methods From January 2016 – October
Externí odkaz:
https://doaj.org/article/699df4b0fc334472a1c15fece5336438
Autor:
Pablo Serrano-Fernandez, Dagmara Dymerska, Grzegorz Kurzawski, Róża Derkacz, Tatiana Sobieszczańska, Zbigniew Banaszkiewicz, Hanno Roomere, Eneli Oitmaa, Andres Metspalu, Ramūnas Janavičius, Pavel Elsakov, Mindaugas Razumas, Kestutis Petrulis, Arvīds Irmejs, Edvīns Miklaševičs, Rodney J. Scott, Jan Lubiński
Publikováno v:
Gastroenterology Research and Practice, Vol 2015 (2015)
The continued identification of new low-penetrance genetic variants for colorectal cancer (CRC) raises the question of their potential cumulative effect among compound carriers. We focused on 6 SNPs (rs380284, rs4464148, rs4779584, rs4939827, rs69832
Externí odkaz:
https://doaj.org/article/0e84904d762f45cbb8bf659e1271863b
Autor:
Elza Kuzņecova, Zanda Daneberga, Egija Berga-Švītiņa, Miki Nakazawa-Miklaševiča, Arvīds Irmejs, Jānis Gardovskis, Edvīns Miklaševičs
Publikováno v:
Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.. 77:33-40
Triple negative breast cancer (TNBC) is a breast cancer subtype characterised by lack of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor, and by worse prognosis than other cancer types. The aim of this study was
Publikováno v:
Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 75, Iss 1, Pp 20-24 (2021)
Breast cancer (BC) is the most common cause of cancer-related deaths among women in Europe and worldwide. Adherent (2D) cell cultures have been the routine in vitro model system employed in preclinical BC research for the last half-century. Over the
Autor:
Reinis Irmejs, Gunta Purkalne, Arvīds Irmejs, Pēteris Loža, Genādijs Trofimovičs, Baiba Līcīte, Māra Romanovska, J. Maksimenko, Justīne Deičmane, Edvīns Miklaševičs, Jānis Gardovskis, Jurijs Nazarovs
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-6 (2021)
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-6 (2021)
Background Aim of the study is to evaluate the role of ultrasound guided fine needle aspiration cytology (FNAC) in the restaging of node positive breast cancer after preoperative systemic therapy (PST). Methods From January 2016 – October 2020 106
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f52cc2500bcd4331c22b59414f994f9
Autor:
Arvīds Irmejs, Justīne Deičmane, Māra Romanovska, Edvīns Miklaševičs, Jānis Gardovskis, J. Maksimenko, Pēteris Loža, Gunta Purkalne, Genādijs Trofimovičs, Baiba Līcīte, Jurijs Nazarovs
Publikováno v:
Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, Vol 73, Iss 4, Pp 368-372 (2019)
The aim of the study was to evaluate the role of ultrasound guided fine needle aspiration cytology (FNAC) in the restaging of node positive breast cancer after neoadjuvant chemotherapy (NAC). From January 2016 – October 2018, 90 node positive stage
Autor:
P. Loza, J. Maksimenko, Edvīns Miklaševičs, Genādijs Trofimovičs, Zanda Daneberga, Signe Subatniece, E. Tauvena, Jānis Gardovskis, Arvīds Irmejs, E. Berga-Svitina, S. Ukleikins
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-8 (2021)
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice
Background Several recent studies in the Baltic region have found extended spectrum of pathogenic variants (PV) of the BRCA1/2 genes. The aim of current study is to analyze the spectrum of the BRCA1/2 PV in population of Latvia and to compare common
Autor:
J. Maksimenko, Janis Gardovskis, Dace Bērziņa, Elīna Skuja, Genādijs Trofimovičs, Gunta Purkalne, Arvīds Irmejs, Edvins Miklasevics
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 16, Iss 1, Pp 1-7 (2018)
Background Pathogenic BRCA1 founder mutations (c.4035delA, c.5266dupC) contribute to 3.77% of all consecutive primary breast cancers and 9.9% of all consecutive primary ovarian cancers. Identifying germline pathogenic gene variants in patients with p
Autor:
Jelena Maksimenko, Arvīds Irmejs, Genādijs Trofimovičs, Edvīns Miklaševičs, Zanda Daneberga, Jānis Gardovskis, P. Loza
Publikováno v:
European Journal of Cancer. 138:S48